Adv Drug Deliv Rev. 2018 Jun 21. pii: S0169-409X(18)30151-0. doi: 10.1016/j.addr.2018.06.012. [Epub ahead of print]

Bioengineered cellular and cell membrane-derived vehicles for actively targeted drug delivery: So near and yet so far.

Thanuja MY¹, Anupama C¹, Ranganath SH².

Abstract

Cellular carriers for drug delivery are attractive alternatives to synthetic nanoparticles owing to their innate homing/targeting abilities. Here, we review molecular interactions involved in the homing of Mesenchymal stem cells (MSCs) and other cell types to understand the process of designing and engineering highly efficient, actively targeting cellular vehicles. In addition, we comprehensively discuss various genetic and non-genetic strategies and propose a few futuristic approaches of engineering MSC homing using micro/nanotechnology and high throughput small molecule screening. Most of the targeting abilities of a cell come from its plasma membrane, thus, efforts to harness cell membranes as drug delivery vehicles are gaining importance and are highlighted here. We also recognize and report the lack of detailed characterization of cell membranes in terms of safety, structural integrity, targeting functionality, and drug transport. Finally, we provide insights on future development of bioengineered cellular and cell membrane-derived vesicles for successful clinical translation.